A new trading day began on Friday, with Cg Oncology Inc (NASDAQ: CGON) stock price up 0.07% from the previous day of trading, before settling in for the closing price of $28.50. CGON’s price has ranged from $25.77 to $50.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -45.67% over the last five years. Meanwhile, its annual earnings per share averaged -13.72%. With a float of $44.94 million, this company’s outstanding shares have now reached $67.54 million.
The firm has a total of 61 workers. Let’s measure their productivity. In terms of profitability, gross margin is 97.81%, operating margin of -13969.15%, and the pretax margin is -10578.22%.
Cg Oncology Inc (CGON) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cg Oncology Inc is 33.54%, while institutional ownership is 75.72%. The most recent insider transaction that took place on Jan 13 ’25, was worth 29,660. In this transaction Director of this company sold 1,000 shares at a rate of $29.66, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Director sold 700,000 for $28.00, making the entire transaction worth $19,600,000. This insider now owns 3,003,931 shares in total.
Cg Oncology Inc (CGON) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.72% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Here are Cg Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 35.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2836.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Analysing the last 5-days average volume posted by the [Cg Oncology Inc, CGON], we can find that recorded value of 0.35 million was lower than the volume posted last year of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 41.14%. Additionally, its Average True Range was 1.22.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 13.03%, which indicates a significant decrease from 43.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.55% in the past 14 days, which was lower than the 44.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.99, while its 200-day Moving Average is $33.51. Now, the first resistance to watch is $29.06. This is followed by the second major resistance level at $29.61. The third major resistance level sits at $29.98. If the price goes on to break the first support level at $28.15, it is likely to go to the next support level at $27.78. Now, if the price goes above the second support level, the third support stands at $27.23.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
With a market capitalization of 1.93 billion, the company has a total of 76,038K Shares Outstanding. Currently, annual sales are 200 K while annual income is -48,610 K. The company’s previous quarter sales were 40 K while its latest quarter income was -20,410 K.
